C4 Therapeutics’ License and Research Collaboration with Merck

Wilson Sonsini Goodrich & Rosati advised C4 Therapeutics on the transaction.C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC) announced that it has entered into an exclusive license and…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now